| 946| Quality of anticoagulation control in patients with atrial fibrillation in Valencia, Spain: A real‐world, population‐based study A Garcia‐Sempere, I Hurtado, D Bejarano‐Quisoboni, ... | | |
| A multilevel analysis of real-world variations in oral anticoagulation initiation for atrial fibrillation in Valencia, a European region A Garcia-Sempere, D Bejarano-Quisoboni, J Librero, ... Frontiers in Pharmacology 8, 576, 2017 | 6 | 2017 |
| Adherence to oral anticoagulant and antiplatelet therapies after an acute ischemic stroke or TIA in atrial fibrillation patients J Riera-Arnau, G Sanfelix-Gimeno, C Liliana Rodriguez-Bernal, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 217-217, 2020 | | 2020 |
| Adherence trajectories to essential medications after acute coronary syndrome and their impact on clinical outcomes. A population-based cohort study D Bejarano-Quisoboni, I Hurtado, CL Rodriguez-Bernal, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 40-41, 2018 | | 2018 |
| Anticoagulant treatment in combination with antiplatelet therapy in patients with coronary artery disease and atrial fibrillation: A comparative effectiveness and safety study … Y Santa-Ana-Tellez, CL Rodriguez-Bernal, A Garcia-Sempere, S Peiro, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 396-397, 2018 | | 2018 |
| Assessing concurrent adherence to combined essential medication and clinical outcomes in patients with acute coronary syndrome. A population-based, real-world study using group … CL Rodriguez-Bernal, F Sanchez-Saez, D Bejarano-Quisoboni, I Hurtado, ... Frontiers in Cardiovascular Medicine 9, 863876, 2022 | 5 | 2022 |
| Association of vitamin K and non‐vitamin K oral anticoagulant use and cancer incidence in atrial fibrillation patients AA Iftimi, CL Rodríguez‐Bernal, S Peiró, S Bonanad, A Ferrero‐Gregori, ... Clinical Pharmacology & Therapeutics 111 (1), 200-208, 2022 | 1 | 2022 |
| Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to … I Hurtado-Navarro, A García-Sempere, C Rodríguez-Bernal, ... Frontiers in Pharmacology 10, 768, 2019 | | 2019 |
| Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population‐based propensity‐weighted cohort study CL Rodríguez‐Bernal, Y Santa‐Ana‐Téllez, A García‐Sempere, I Hurtado, ... British Journal of Clinical Pharmacology 87 (2), 632-643, 2021 | 9 | 2021 |
| Comparative effectiveness and safety of low-dose non-vitamin K oral anticoagulants and acenocoumarol in patients with atrial fibrillation in Valencia, Spain Y Santa-Ana-Tellez, CL Rodriguez-Bernal, A Garcia-Sempere, S Peiro, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 35-35, 2018 | | 2018 |
| Comparative effectiveness and safety of non-vitamin K oral anticoagulants and acenocoumarol in patients with atrial fibrillation: A propensity-weighted cohort study C Rodriguez-Bernal, Y Santa-Ana Tellez, A Garcia-Sempere, I Hurtado, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 399-400, 2018 | | 2018 |
| Cost of illness studies: conceptual framework, limits and results in Spain A García-Sempere, E Portella Adicciones 14 (1), 2002 | 1 | 2002 |
| Cost-sharing increase, adherence and hospitalizations in schizophrenic patients: A population-based difference-in-differences analysis in the Valencia region, Spain M Serra-Burriel, I Hurtado, A Garcia-Sempere, G Sanfelix-Gimeno, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 317-317, 2020 | | 2020 |
| Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment M Serra‐Burriel, I Hurtado, G Sanfélix‐Gimeno, A García‐Sempere, ... Clinical Pharmacology & Therapeutics 110 (6), 1490-1497, 2021 | 1 | 2021 |
| Data resource profile: the Valencia health system integrated database (VID) A García-Sempere, A Orrico-Sánchez, C Muñoz-Quiles, I Hurtado, S Peiró, ... International Journal of Epidemiology 49 (3), 740-741e, 2020 | 45 | 2020 |
| Datos de vida real para la mejora de la utilización y la efectividad de los medicamentos en el sistema nacional de salud: contribuciones esenciales AG Sempere Universitat de València, 2020 | | 2020 |
| Drug expenditure in primary care: associated variables and allocation of drug budgets according to health district A Garcia-Sempere, S Peiro Gaceta sanitaria 15 (1), 32-40, 2001 | 9 | 2001 |
| Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome BGL Valcárcel, J Librero, A García-Sempere, LM Peña, S Bauer, ... | | 2017 |
| Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome BG López-Valcárcel, J Librero, A García-Sempere, LM Peña, S Bauer, ... Heart 103 (14), 1082-1088, 2017 | 43 | 2017 |
| Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome: A Population Based Natural Experiment B González, J Librero, LM Peña-Logobardo, S Bauer, A García-Sempere, ... Value in Health 19 (7), A659, 2016 | 3 | 2016 |
